BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Sandoz lance le premier biosimilaire de la sclérose en plaques, TYRUKO®, aux États-Unis. Sclérose En Plaques Biosimilaire Sandoz TYRUKO® Natalizumab
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Siegfried AG Announces CFO Transition Pharmaceutical Industry CFO Transition Siegfried AG Tania Micki Reto Suter
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Siegfried AG annonce un changement de directeur financier Industrie Pharmaceutique Transition Du Directeur Financier Siegfried AG Tania Micki Reto Suter
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Cicor Secures Major Orders and Expands with Valtronic Acquisition Acquisition European Market Order Intake Aerospace & Defence Valtronic Sites
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Cicor décroche d'importantes commandes et se développe grâce à l'acquisition de Valtronic. Acquisition Marché Européen Prise De Commande Aérospatiale Et Défense Sites Valtronic
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Pluxee Maintient des Perspectives Prudentes pour 2026 Suite à une Réforme au Brésil Interopérabilité Action En Justice Pluxee Perspectives 2026 Réforme Brésil
BRIEF published on 11/17/2025 at 07:05, 2 months 16 days ago Pluxee Maintains Cautious Outlook for 2026 Following Reform in Brazil Interoperability Legal Action Outlook 2026 Pluslee Brazil Reform
BRIEF published on 11/17/2025 at 06:35, 2 months 16 days ago Formycon Reaches Milestone with FYB208 for Dupixent® Biosimilars Formycon Chronic Inflammatory Diseases Dupilumab Technical Proof Of Similarity
Published on 02/03/2026 at 11:30, 35 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Dr. Christoph Themel as Partner
Published on 02/03/2026 at 09:01, 3 hours 4 minutes ago Star Copper Completes Copperline Field Program with Drill Permit Submitted for 2026
Published on 02/02/2026 at 23:55, 12 hours 10 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 12 hours 10 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 12 hours 40 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/03/2026 at 11:55, 10 minutes ago IGI Acquires AGL, Expanding its Global Footprint in Colored Gemstone Certification
Published on 02/03/2026 at 11:15, 49 minutes ago EQS-Adhoc: hGears AG Group: Preliminary revenue and adjusted EBITDA for 2025 slightly above Management’s guidance; free cash flow affected by reclassification effect
Published on 02/03/2026 at 11:05, 1 hour ago 2026 International AI Safety Report Charts Rapid Changes and Emerging Risks
Published on 02/03/2026 at 08:30, 3 hours 35 minutes ago cegedim.cloud lance la nouvelle version d’Enercare, son module de calcul et de pilotage de l’empreinte carbone
Published on 02/03/2026 at 08:00, 4 hours 5 minutes ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 4 hours 5 minutes ago EURAZEO ET PANTHEON METTENT EN PLACE UN VÉHICULE DE CONTINUATION DE DETTE PRIVÉE DE PRÈS DE €500 MILLIONS
Published on 02/03/2026 at 08:00, 4 hours 5 minutes ago Neoen lance la construction de trois nouveaux parcs solaires en France pour une capacité totale de 230 MWc
Published on 02/03/2026 at 08:00, 4 hours 5 minutes ago Neoen launches three new solar farms in France with a total capacity of 230 MWp
